[13C2, 15N3]-Tazobactam sodium salt

[13C2, 15N3]-Tazobactam sodium salt is a potent antibacterial drug, which is used for the treatment of various bacterial infections. It is a member of the beta-lactamase inhibitor class of drugs and is often combined with other antibiotics to increase their effectiveness. Chemically, [13C2, 15N3]-Tazobactam sodium salt is a sodium salt of [13C2, 15N3]-tazobactam, a stable isotopically labeled derivative of tazobactam. The stable isotopes used in its synthesis make it useful for tracing metabolic pathways and understanding the mechanism of action of the drug. The drug works by inhibiting beta-lactamases, which are enzymes produced by some bacteria to break down beta-lactam antibiotics. By inhibiting these enzymes, [13C2, 15N3]-Tazobactam sodium salt renders the bacteria vulnerable to the antibiotic, allowing it to attack and kill the bacteria. [13C2, 15N3]-Tazobactam sodium salt is administered intravenously and is typically used in hospital settings to treat complicated bacterial infections such as pneumonia, urinary tract infections, and intra-abdominal infections. It has a broad spectrum of activity against gram-positive and gram-negative bacteria, including those that are resistant to other antibiotics. Overall, [13C2, 15N3]-Tazobactam sodium salt is a valuable tool in the fight against bacterial infections and its stable isotopic labeling provides a unique opportunity for research into the mechanisms of bacterial resistance and antibiotic effectiveness.